168 related articles for article (PubMed ID: 34750466)
1. The FcεRI signaling pathway is involved in the pathogenesis of lacrimal gland benign lymphoepithelial lesions as shown by transcriptomic analysis.
Li J; Liu R; Sun M; Wang J; Wang N; Zhang X; Ge X; Ma J
Sci Rep; 2021 Nov; 11(1):21853. PubMed ID: 34750466
[TBL] [Abstract][Full Text] [Related]
2. B cell receptor signaling pathway involved in benign lymphoepithelial lesions of the lacrimal gland.
Wang XN; Ge X; Li J; Liu X; Ma JM
Int J Ophthalmol; 2017; 10(5):665-669. PubMed ID: 28546918
[TBL] [Abstract][Full Text] [Related]
3. Association of TCR-signaling pathway with the development of lacrimal gland benign lymphoepithelial lesions.
Ma JM; Cui YX; Ge X; Li J; Li JR; Wang XN
Int J Ophthalmol; 2015; 8(4):685-9. PubMed ID: 26309862
[TBL] [Abstract][Full Text] [Related]
4. Missing link between tissue specific expressing pattern of ERβ and the clinical manifestations in LGBLEL.
Zhang X; Zhao P; Ma M; Wu H; Liu R; Liu Z; Cai Z; Liu M; Xie F; Ma X
Front Med (Lausanne); 2023; 10():1168977. PubMed ID: 37457559
[TBL] [Abstract][Full Text] [Related]
5. Association analysis of BclI with benign lymphoepithelial lesions of the lacrimal gland and glucocorticoids resistance.
Zhang XJ; Zhao PX; Ma MS; Wu H; Liu R; Wang H; Liu MY; Xie F; Ma XM
Int J Ophthalmol; 2023; 16(11):1734-1745. PubMed ID: 38028530
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Efficacy of Immune and Inflammatory Markers in the Diagnosis of Lacrimal-Gland Benign Lymphoepithelial Lesion.
Luan F; Liu R; Li J; Ge X; Wang N; Guo Q; Tao Y; Ma J
Curr Issues Mol Biol; 2023 Mar; 45(3):2013-2020. PubMed ID: 36975499
[TBL] [Abstract][Full Text] [Related]
7. Gene Expression Profiling and Heterogeneity of Nonspecific Orbital Inflammation Affecting the Lacrimal Gland.
Rosenbaum JT; Choi D; Harrington CA; Wilson DJ; Grossniklaus HE; Sibley CH; Salek SS; Ng JD; Dailey RA; Steele EA; Hayek B; Craven CM; Edward DP; Maktabi AMY; Al Hussain H; White VA; Dolman PJ; Czyz CN; Foster JA; Harris GJ; Bee YS; Tse DT; Alabiad CR; Dubovy SR; Kazim M; Selva D; Yeatts RP; Korn BS; Kikkawa DO; Silkiss RZ; Sivak-Callcott JA; Stauffer P; Planck SR
JAMA Ophthalmol; 2017 Nov; 135(11):1156-1162. PubMed ID: 28975236
[TBL] [Abstract][Full Text] [Related]
8. Different serum levels of IgG and complements and recurrence rates in IgG4-positive and negative lacrimal gland benign lymphoepithelial lesion.
Liu R; Wang N; Wang JJ; Li J; Ge X; Zhang JX; Ma JM
Int J Ophthalmol; 2023; 16(6):876-883. PubMed ID: 37332559
[TBL] [Abstract][Full Text] [Related]
9. Complement System in the Pathogenesis of Benign Lymphoepithelial Lesions of the Lacrimal Gland.
Li J; Ge X; Wang X; Liu X; Ma J
PLoS One; 2016; 11(2):e0148290. PubMed ID: 26849056
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of AMPK through Lyn-Syk-Akt enhances FcεRI signal pathways for allergic response.
Lin KC; Huang DY; Huang DW; Tzeng SJ; Lin WW
J Mol Med (Berl); 2016 Feb; 94(2):183-94. PubMed ID: 26373430
[TBL] [Abstract][Full Text] [Related]
11. Tumours of the lacrimal gland. Epidemiological, clinical and genetic characteristics.
von Holstein SL
Acta Ophthalmol; 2013 Nov; 91 Thesis 6():1-28. PubMed ID: 24893972
[TBL] [Abstract][Full Text] [Related]
12. [Clinical histopathologic characteristics of lacrimal glands in lacrimal gland prolapse with blepharochalasis].
Xin Y; Xu XL; Li Y; Ding JW; Li DM
Zhonghua Yan Ke Za Zhi; 2020 Mar; 56(3):205-210. PubMed ID: 32187949
[No Abstract] [Full Text] [Related]
13. [The expression of cluster of differentiation 44 variant 6 and fibronectin in lacrimal gland tumors].
Niu YJ; Liu FL; Yang WY; Lin H; Wang HY
Zhonghua Yan Ke Za Zhi; 2004 Sep; 40(9):620-4. PubMed ID: 15500768
[TBL] [Abstract][Full Text] [Related]
14. Intra-lacrimal gland cavernous hemangioma.
Char DH; Barakos JA; Moretto J
Orbit; 2010 Dec; 29(6):354-6. PubMed ID: 21158578
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphorylation of the vav proto-oncogene product links FcepsilonRI to the Rac1-JNK pathway.
Teramoto H; Salem P; Robbins KC; Bustelo XR; Gutkind JS
J Biol Chem; 1997 Apr; 272(16):10751-5. PubMed ID: 9099726
[TBL] [Abstract][Full Text] [Related]
16. C-KIT Expression in Orbital Cavernous Venous Hemangiomas.
Atallah M; Edison N; Levi E; Elmalah I; Briscoe D
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439864
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 2 agonist Pam3CSK4 up-regulates FcεRI receptor expression on monocytes from patients with severe extrinsic atopic dermatitis.
Song Z; Deng X; Chen W; Xu J; Chen S; Zhong H; Hao F
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2169-76. PubMed ID: 25912722
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical characterization of epithelial cells in human lacrimal glands. II. Inflammatory and neoplastic lesions of lacrimal glands.
Wilk CM; Vigneswaran N; Heese A; Hornstein OP; Naumann GO
Graefes Arch Clin Exp Ophthalmol; 1990; 228(1):65-72. PubMed ID: 1690161
[TBL] [Abstract][Full Text] [Related]
19. The cytologic composition of dacryops: an immunohistochemical investigation of 15 lesions compared to the normal lacrimal gland.
Jakobiec FA; Zakka FR; Perry LP
Am J Ophthalmol; 2013 Feb; 155(2):380-396.e1. PubMed ID: 23114708
[TBL] [Abstract][Full Text] [Related]
20. [Histopathologic classification of 1921 orbital tumors].
Ni C; Ma X
Yan Ke Xue Bao; 1995 Jun; 11(2):101-4. PubMed ID: 9208664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
